The use of nanoscaffolds and dendrimers in tissue engineering

Drug Discov Today. 2017 Apr;22(4):652-664. doi: 10.1016/j.drudis.2016.12.007. Epub 2017 Feb 20.


To avoid tissue rejection during organ transplantation, research has focused on the use of tissue engineering to regenerate required tissues or organs for patients. The biomedical applications of hyperbranched, multivalent, structurally uniform, biocompatible dendrimers in tissue engineering include the mimicking of natural extracellular matrices (ECMs) in the 3D microenvironment. Dendrimers are unimolecular architects that can incorporate a variety of biological and/or chemical substances in a 3D architecture to actively support the scaffold microenvironment during cell growth. Here, we review the use of dendritic delivery systems in tissue engineering. We discuss the available literature, highlighting the 3D architecture and preparation of these nanoscaffolds, and also review challenges to, and advances in, the use dendrimers in tissue engineering. Advances in the manufacturing of dendritic nanoparticles and scaffold architectures have resulted in the successful incorporation of dendritic scaffolds in tissue engineering.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biocompatible Materials / administration & dosage
  • Dendrimers / therapeutic use*
  • Drug Delivery Systems / methods
  • Humans
  • Nanoparticles / administration & dosage*
  • Regeneration / drug effects
  • Tissue Engineering / methods
  • Tissue Scaffolds


  • Biocompatible Materials
  • Dendrimers